Caption Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Caption Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-134,500	Closed	-$6.95M	–	1883
2022 Q3	$6.95M	Buy	134,500 +77,000	+134%	+$3.18M	0.1%	257
2022 Q2	$1.43M	Sell	57,500 -207,500	-78%	-$4.57M	0.02%	759
2022 Q1	$6.64M	Buy	265,000 +124,400	+88%	+$3.5M	0.08%	337
2021 Q4	$5.12M	Sell	140,600 -530,500	-79%	-$18.6M	0.06%	450
2021 Q3	$11.5M	Buy	671,100 +271,100	+68%	+$4.22M	0.13%	206
2021 Q2	$5.36M	Buy	400,000 +355,000	+789%	+$8.75M	0.07%	355
2021 Q1	$2.31M	Buy	+45,000	New	+$2.71M	0.05%	478
2020 Q4	–	Sell	-110,000	Closed	-$6.03M	–	1327
2020 Q3	$6.03M	Sell	110,000 -120,000	-52%	-$6.46M	0.14%	172
2020 Q2	$13.2M	Buy	+230,000	New	+$12.5M	0.44%	30
2019 Q4	–	Sell	-25,000	Closed	-$169K	–	1049
2019 Q3	$169K	Hold	25,000	–	–	0.01%	601
2019 Q2	$233K	Buy	+25,000	New	+$289K	0.01%	552

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Caption Management's CCXI Position: Q4 2022 in Review

Caption Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 4,900 shares — an estimated $252K sold.

Caption Management first reported a position in CCXI in Q2 2019 and held it in 11 quarters. The position peaked at $7.78M in Q1 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Caption Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Caption Management sold 4,900 ChemoCentryx, Inc. shares in Q4 2022, an estimated $252K.
Caption Management first reported a position in ChemoCentryx, Inc. in Q2 2019 and held it in 11 quarters.
Caption Management's ChemoCentryx, Inc. position peaked at $7.78M in Q1 2020.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.